Molecular and cellular mechanisms of estrogen action on the skeleton

The many recent and exciting advances that have taken place in the field of estrogen action on the skeleton are the subjects of this review. Leading these new developments is the discovery of alternative estrogen receptors that exhibit differential mechanisms of transcriptional control of estrogen‐responsive promoters, thereby broadening both the ranges of possible target cells and their responses. More potentially important genes under estrogenic control have been identified in vitro, and the skeletal phenotypes caused by disruption of estrogen signaling due to mutations in humans and mice have been described. Lastly, clinical studies in humans have revealed a greater appreciation for the importance of estrogen in bone mass maintenance in both sexes. J. Cell. Biochem. Suppls. 32/33:123–132, 1999. © 1999 Wiley‐Liss, Inc.

[1]  P. Webb,et al.  Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. , 1997, Endocrinology.

[2]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.

[3]  R. Jilka,et al.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.

[4]  G. Mundy,et al.  Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β , 1996, Nature Medicine.

[5]  B. Riggs,et al.  Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Maran,et al.  Estrogen has rapid tissue-specific effects on rat bone. , 1999, Journal of applied physiology.

[7]  B. Riggs,et al.  Avian osteoclasts as estrogen target cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Gustafsson,et al.  Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. , 1999, The Journal of clinical investigation.

[9]  K. Korach,et al.  Effect of testosterone and estradiol in a man with aromatase deficiency. , 1997, The New England journal of medicine.

[10]  R T Turner,et al.  Skeletal effects of estrogen. , 1994, Endocrine reviews.

[11]  D. Lacey,et al.  Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. , 1999, Endocrinology.

[12]  V. Jordan,et al.  Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  J. Gustafsson,et al.  The novel estrogen receptor‐β subtype: potential role in the cell‐ and promoter‐specific actions of estrogens and anti‐estrogens , 1997, FEBS letters.

[14]  J. A. Robinson,et al.  Estrogen Regulation of Human Osteoblastic Cell Proliferation and Differentiation* , 2022 .

[15]  H. Pols,et al.  Differential Expression of Estrogen Receptors α and β mRNA During Differentiation of Human Osteoblast SV-HFO Cells. , 1997, Endocrinology.

[16]  B. O’Malley,et al.  Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. , 1997, Molecular endocrinology.

[17]  A. Freemont,et al.  Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction. , 1997, Bone.

[18]  H. Lee,et al.  A PCR Analysis of ERα and ERβ mRNA Abundance in Rats and the Effect of Ovariectomy , 1999 .

[19]  K. Korach,et al.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.

[20]  B. Komm,et al.  Functional properties of a conditionally phenotypic, estrogen‐responsive, human osteoblast cell line , 1997, Journal of cellular biochemistry.

[21]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[22]  B Stein,et al.  Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta , 1995, Molecular and cellular biology.

[23]  E. Barrett-Connor,et al.  Endogenous Sex Steroids and Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  M. Lieberherr,et al.  Cell signaling and estrogens in female rat osteoblasts: A possible involvement of unconventional nonnuclear receptors , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  H Grøn,et al.  Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  B. L. Riggs,et al.  A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging Men , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  Kenneth G. Mann,et al.  Evidence of estrogen receptors in normal human osteoblast-like cells , 1988 .

[28]  G. Rodan,et al.  Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element. , 1991, Molecular endocrinology.

[29]  R. Kimble,et al.  Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. , 1995, Endocrinology.

[30]  G. Jenster,et al.  Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. , 1997, Recent progress in hormone research.

[31]  K. Korach,et al.  Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. , 1996, Recent progress in hormone research.

[32]  J. Milbrandt,et al.  Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. , 1998, The Journal of clinical investigation.

[33]  B. Komm,et al.  Estrogen Receptor-α Is Developmentally Regulated during Osteoblast Differentiation and Contributes to Selective Responsiveness of Gene Expression. , 1998, Endocrinology.

[34]  B. Riggs,et al.  The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. , 1999, Molecular endocrinology.

[35]  R. L. Moss,et al.  Estrogen: nontranscriptional signaling pathway. , 1997, Recent progress in hormone research.

[36]  Y. Yamasaki,et al.  Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. , 1994, The Journal of biological chemistry.

[37]  B. Riggs,et al.  Estrogen response in the hFOB 1.19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene , 1995, Journal of cellular biochemistry.